ENvue Medical, Inc. FEED
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.93M | 2.18M | 2.55M | 2.69M | 2.34M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.93M | 2.18M | 2.55M | 2.69M | 2.34M |
| Cost of Revenue | 2.43M | 2.45M | 2.40M | 1.88M | 1.59M |
| Gross Profit | -502.00K | -271.00K | 153.00K | 806.00K | 750.00K |
| SG&A Expenses | 13.35M | 11.58M | 10.08M | 8.13M | 6.77M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.02M | 15.78M | 14.29M | 12.13M | 10.51M |
| Operating Income | -15.09M | -13.59M | -11.74M | -9.45M | -8.17M |
| Income Before Tax | -21.42M | -20.42M | -18.49M | -6.65M | -8.19M |
| Income Tax Expenses | -353.00K | -289.00K | -307.00K | 117.00K | 85.00K |
| Earnings from Continuing Operations | -21.06 | -20.14 | -18.19 | -6.76 | -8.27 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.06M | -20.14M | -18.19M | -6.76M | -8.27M |
| EBIT | -15.09M | -13.59M | -11.74M | -9.45M | -8.17M |
| EBITDA | -14.14M | -12.50M | -10.84M | -8.81M | -7.79M |
| EPS Basic | -265.58 | -254.25 | -214.44 | -108.73 | -140.55 |
| Normalized Basic EPS | -24.34 | -78.88 | -70.24 | -55.66 | -87.12 |
| EPS Diluted | -265.58 | -254.25 | -214.44 | -108.73 | -140.55 |
| Normalized Diluted EPS | -24.34 | -78.88 | -70.24 | -55.66 | -87.12 |
| Average Basic Shares Outstanding | 950.50K | 477.80K | 203.70K | 111.90K | 63.80K |
| Average Diluted Shares Outstanding | 950.50K | 477.80K | 227.10K | 158.70K | 110.60K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |